Immunic

$17.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+0.98%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Immunic and other stocks, options, and ETFs commission-free!

About IMUX

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA. The listed name for IMUX is Immunic, Inc. Common Stock.

CEO
Daniel Vitt
Employees
26
Headquarters
New York, New York
Founded
Market Cap
363.61M
Price-Earnings Ratio
Dividend Yield
Average Volume
403.68K
High Today
$17.63
Low Today
$17.18
Open Price
$17.46
Volume
117.21K
52 Week High
$23.39
52 Week Low
$4.19

Collections

IMUX Earnings

-$1.52
-$1.01
-$0.51
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, After Hours

You May Also Like